OXFORD ASSET MANAGEMENT LLP - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 228 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.97 and the average weighting 0.2%.

Quarter-by-quarter ownership
OXFORD ASSET MANAGEMENT LLP ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$801,000
-44.1%
17,684
-53.1%
0.02%
-35.3%
Q3 2019$1,434,000
+4.7%
37,677
+19.6%
0.03%
+17.2%
Q2 2019$1,370,000
+32.1%
31,512
+15.6%
0.03%
+26.1%
Q1 2019$1,037,000
-55.8%
27,251
-50.0%
0.02%
-62.3%
Q4 2018$2,345,000
+34.8%
54,506
+53.9%
0.06%
+69.4%
Q3 2018$1,739,000
+12.2%
35,421
-29.1%
0.04%
+20.0%
Q2 2018$1,550,000
+181.8%
49,924
+182.8%
0.03%
+150.0%
Q1 2018$550,000
-87.8%
17,653
-82.1%
0.01%
-87.6%
Q4 2017$4,493,000
+77.9%
98,865
+51.5%
0.10%
+98.0%
Q3 2017$2,525,000
-13.6%
65,241
+6.4%
0.05%
-15.5%
Q2 2017$2,924,000
+284.2%
61,308
+267.2%
0.06%
+205.3%
Q1 2017$761,000
-22.3%
16,698
-42.5%
0.02%
-40.6%
Q2 2016$980,000
-92.6%
29,061
-82.9%
0.03%
-89.7%
Q4 2015$13,189,000
+1025.3%
170,199
+497.1%
0.31%
+740.5%
Q3 2015$1,172,000
-42.4%
28,504
-1.0%
0.04%
-32.7%
Q2 2015$2,035,000
-76.4%
28,779
-70.3%
0.06%
-74.9%
Q1 2015$8,609,000
-22.3%
96,891
-21.4%
0.22%
-10.2%
Q4 2014$11,080,000
-28.1%
123,299
-20.6%
0.24%
-30.7%
Q3 2014$15,400,000
+13.9%
155,313
+5.4%
0.35%
-19.8%
Q2 2014$13,517,000
+510.0%
147,424
+220.0%
0.44%
+795.9%
Q3 2013$2,216,000
-39.4%
46,071
-63.5%
0.05%
-50.5%
Q2 2013$3,658,000126,1220.10%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Gagnon Advisors, LLC 251,140$19,167,0008.83%
GAGNON SECURITIES LLC 610,933$46,626,0007.60%
Tamarack Advisers, LP 205,000$15,646,0007.40%
Spyglass Capital Management LLC 1,871,040$142,798,0004.88%
Lisanti Capital Growth, LLC 302,413$23,080,0002.59%
Rock Springs Capital Management LP 1,000,000$76,320,0001.92%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 208,197$15,890,0001.76%
JABODON PT CO 49,052$3,744,0001.70%
Zweig-DiMenna Associates LLC 166,675$12,721,0001.70%
NEUMEIER POMA INVESTMENT COUNSEL LLC 317,425$24,226,0001.63%
View complete list of PACIRA PHARMACEUTICALS INC shareholders